XML 28 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (6,170,045) $ (8,374,415)
Adjustments for:    
Depreciation and amortization 186,049 183,471
Share-based compensation 537,492 1,246,457
Gain on payable forgiveness (14,766) 0
Increase (Decrease) in Operating Capital [Abstract]    
Accounts and other receivable 356,339 562,770
Prepaid expenses and other current assets 197,136 301,504
Accounts payable and accrued liabilities 17,590 (556,270)
Net cash used in operating activities (4,890,205) (6,636,483)
Cash flows from financing activities:    
Proceeds from issuance of common shares and warrants 729,387 4,345,017
Proceeds from exercise of warrants 0 770,532
Payments for issuance costs of common shares and warrants (107,824) (285,438)
Repayment of debt (29,532) 0
Net cash provided by financing activities 592,031 4,830,111
Effect of exchange rate changes on cash and cash equivalents (25,903) 76,850
Net change in cash and cash equivalents (4,324,077) (1,729,522)
Cash and cash equivalents, beginning of period 5,361,397 7,090,919
Cash and cash equivalents, end of period $ 1,037,320 $ 5,361,397